company background image

Lagis Enterprise TPEX:6730 Stock Report

Last Price


Market Cap







07 Aug, 2022


Company Financials
6730 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance4/6
Financial Health6/6

6730 Stock Overview

Lagis Enterprise Co., Ltd., a medical device development company, develops and markets medical devices for the laparoscopic and endoscopic surgical markets worldwide.

Lagis Enterprise Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Lagis Enterprise
Historical stock prices
Current Share PriceNT$35.25
52 Week HighNT$41.85
52 Week LowNT$29.90
1 Month Change-5.87%
3 Month Change-12.10%
1 Year Change-3.95%
3 Year Changen/a
5 Year Changen/a
Change since IPO-52.06%

Recent News & Updates

Shareholder Returns

6730TW Medical EquipmentTW Market

Return vs Industry: 6730 exceeded the TW Medical Equipment industry which returned -8.2% over the past year.

Return vs Market: 6730 exceeded the TW Market which returned -14.4% over the past year.

Price Volatility

Is 6730's price volatile compared to industry and market?
6730 volatility
6730 Average Weekly Movement4.1%
Medical Equipment Industry Average Movement5.2%
Market Average Movement5.1%
10% most volatile stocks in TW Market8.4%
10% least volatile stocks in TW Market2.5%

Stable Share Price: 6730 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: 6730's weekly volatility (4%) has been stable over the past year.

About the Company


Lagis Enterprise Co., Ltd., a medical device development company, develops and markets medical devices for the laparoscopic and endoscopic surgical markets worldwide. Its products include trocars, single port surgery devices, and wound protectors; endo devices, such as hand instruments and advanced bipolar devices; specimen retrieval products; suction irrigation systems and irrigation pumps; training systems; and related accessories. The company was founded in 1993 and is headquartered in Taichung, Taiwan.

Lagis Enterprise Fundamentals Summary

How do Lagis Enterprise's earnings and revenue compare to its market cap?
6730 fundamental statistics
Market CapNT$1.13b
Earnings (TTM)NT$48.94m
Revenue (TTM)NT$393.04m


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
6730 income statement (TTM)
Cost of RevenueNT$214.76m
Gross ProfitNT$178.28m
Other ExpensesNT$129.34m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date


Earnings per share (EPS)1.53
Gross Margin45.36%
Net Profit Margin12.45%
Debt/Equity Ratio0%

How did 6730 perform over the long term?

See historical performance and comparison



Current Dividend Yield


Payout Ratio
We’ve recently updated our valuation analysis.


Is 6730 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score


Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 6730?

Other financial metrics that can be useful for relative valuation.

6730 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2.5x
Enterprise Value/EBITDA11.2x
PEG Ration/a

Price to Earnings Ratio vs Peers

How does 6730's PE Ratio compare to its peers?

6730 PE Ratio vs Peers
The above table shows the PE ratio for 6730 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average24.9x
4744 CVC Technologies
4161 Bioptik Technology Incorporation
4138 Dynamic Medical Technologies
6527 Crystalvue Medical
6730 Lagis Enterprise

Price-To-Earnings vs Peers: 6730 is good value based on its Price-To-Earnings Ratio (23.1x) compared to the peer average (24.9x).

Price to Earnings Ratio vs Industry

How does 6730's PE Ratio compare vs other companies in the TW Medical Equipment Industry?

Price-To-Earnings vs Industry: 6730 is expensive based on its Price-To-Earnings Ratio (23.1x) compared to the TW Medical Equipment industry average (19.6x)

Price to Earnings Ratio vs Fair Ratio

What is 6730's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6730 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio23.1x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 6730's Price-To-Earnings Fair Ratio for valuation analysis.

Share Price vs Fair Value

What is the Fair Price of 6730 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 6730 (NT$35.25) is trading below our estimate of fair value (NT$42.34)

Significantly Below Fair Value: 6730 is trading below fair value, but not by a significant amount.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Future Growth

How is Lagis Enterprise forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score


Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Lagis Enterprise has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Discover growth companies

Past Performance

How has Lagis Enterprise performed over the past 5 years?

Past Performance Score


Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 6730 has high quality earnings.

Growing Profit Margin: 6730's current net profit margins (12.5%) are higher than last year (10.1%).

Past Earnings Growth Analysis

Earnings Trend: 6730's earnings have declined by 16.3% per year over the past 5 years.

Accelerating Growth: 6730's earnings growth over the past year (51.4%) exceeds its 5-year average (-16.3% per year).

Earnings vs Industry: 6730 earnings growth over the past year (51.4%) exceeded the Medical Equipment industry 13.7%.

Return on Equity

High ROE: 6730's Return on Equity (9.9%) is considered low.

Discover strong past performing companies

Financial Health

How is Lagis Enterprise's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 6730's short term assets (NT$316.3M) exceed its short term liabilities (NT$93.4M).

Long Term Liabilities: 6730's short term assets (NT$316.3M) exceed its long term liabilities (NT$5.5M).

Debt to Equity History and Analysis

Debt Level: 6730 is debt free.

Reducing Debt: 6730 has no debt compared to 5 years ago when its debt to equity ratio was 23.3%.

Debt Coverage: 6730 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 6730 has no debt, therefore coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies


What is Lagis Enterprise current dividend yield, its reliability and sustainability?

Dividend Score


Dividend Score 3/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


Current Dividend Yield

Dividend Yield vs Market

Notable Dividend: 6730's dividend (2.84%) is higher than the bottom 25% of dividend payers in the TW market (2.55%).

High Dividend: 6730's dividend (2.84%) is low compared to the top 25% of dividend payers in the TW market (6.64%).

Stability and Growth of Payments

Stable Dividend: 6730 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 6730 has only been paying a dividend for 2 years, and since then payments have fallen.

Earnings Payout to Shareholders

Earnings Coverage: With its reasonable payout ratio (65.4%), 6730's dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (48%), 6730's dividend payments are well covered by cash flows.

Discover strong dividend paying companies


How experienced are the management team and are they aligned to shareholders interests?


Lagis Enterprise has no CEO, or we have no data on them.


Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Company Information

Lagis Enterprise Co., Ltd.'s employee growth, exchange listings and data sources

Key Information

  • Name: Lagis Enterprise Co., Ltd.
  • Ticker: 6730
  • Exchange: TPEX
  • Founded: 1993
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: NT$1.128b
  • Shares outstanding: 32.00m
  • Website:

Number of Employees


  • Lagis Enterprise Co., Ltd.
  • No.29, Gong 1st Road
  • Dajia
  • Taichung
  • 43767
  • Taiwan


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/07 00:00
End of Day Share Price2022/08/05 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.